Medications for Chronic Spontaneous Urticaria

2 results
  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    DUPIXENT treats moderate-to-severe atopic dermatitis (6 months+), asthma (6 years+), chronic rhinosinusitis with nasal polyps (12 years+), eosinophilic esophagitis (1 year+), prurigo nodularis, COPD, chronic spontaneous urticaria (12 years+), bullous pemphigoid, and allergic fungal rhinosinusitis in eligible adult and pediatric patients.
  • xolair - omalizumab injection, solution

    (Omalizumab)
    Genentech, Inc.
    Xolair treats moderate-to-severe persistent asthma (ages 6+) with perennial allergen sensitivity, chronic rhinosinusitis with nasal polyps (adults 18+), IgE-mediated food allergy (ages 1+) to reduce accidental exposure reactions, and chronic spontaneous urticaria (ages 12+) uncontrolled by antihistamines.